Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy

The approval of different cytokines as anti-neoplastic agents has been challenged by dose-limiting toxicities. Although reducing dose levels affords improved tolerability, efficacy is precluded at these suboptimal doses. Strategies combining cytokines with oncolytic viruses have proven to elicit pot...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Nikolas T., Crupi, Mathieu J. F., Taha, Zaid, Poutou, Joanna, Whelan, Jack T., Vallati, Sydney, Petryk, Julia, Marius, Ricardo, Austin, Bradley, Azad, Taha, Boulanger, Mason, Burgess, Tamara, Sanders, Ilson, Victoor, Camille, Dickinson, Bryan C., Diallo, Jean-Simon, Ilkow, Carolina S., Bell, John C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224353/
https://www.ncbi.nlm.nih.gov/pubmed/37242495
http://dx.doi.org/10.3390/ph16050709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224353/
https://www.ncbi.nlm.nih.gov/pubmed/37242495
http://dx.doi.org/10.3390/ph16050709

Ejemplares similares